Is this you? Create Your Porfile
Avatar

Thomas Caulfield

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Thomas Caulfield is active.

Explore More

Publication

Featured researches published by Thomas Caulfield.

Archive | 2000

DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS

Zaid Jayyosi; Gerard M. Mcgeehan; Michael F. Kelley; Richard Labaudiniere; Litao Zhang; Robert Groneberg; Daniel G. Mcgarry; Thomas Caulfield; Anne Minnich; Mark Bobko

Archive | 2000

Therapeutic uses of di-aryl acid derivatives

Zaid Jayyosi; Gerard M. Mcgeehan; Michael F. Kelley; Richard F. Labaudiniere; Litao Zhang; Robert D. Groneberg; Daniel G. Mcgarry; Thomas Caulfield; Anne Minnich; Mark Exton Bobko

Archive | 2004

Chemical derivatives and their application as antitelomerase agents

Patrick Mailliet; Abdelazize Laoui; Jean-François Riou; Gilles Doerflinger; Jean-Louis Mergny; Francois Hamy; Thomas Caulfield

Archive | 2002

Chemical derivatives and their use as anti-telomerase agent

Patrick Mailliet; Abdelazize Laoui; Jean-François Riou; Gilles Doerflinger; Jean-Louis Mergny; Francois Hamy; Thomas Caulfield

ACS Combinatorial Science | 2000

Parallel solid-phase synthesis of peptidyl Michael acceptors.

Thomas Caulfield; Sharmila Patel; Joseph M. Salvino; Lara Liester; Richard Labaudiniere

Archive | 2004

Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent

Augustin Hittinger; Thomas Caulfield; Patrick Mailliet; Herve Bouchard; Eliane Mandine; Jean-Louis Mergny; Lionel Guittat; Jean-François Riou; Dennis Gomez; Chafke Belmokhtar

Archive | 2002

1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof

Patrick Mailliet; Cécile Combeau; Marie-Christine Bissery; Marie-Pierre Cherrier; Thomas Caulfield; Gilles Tiraboschi

Archive | 2002

Triazine derivatives and their application as antitelomerase agents

Patrick Mailliet; Abdelazize Laoui; Jean-François Riou; Gilles Doerflinger; Jean-Louis Mergny; Francois Hamy; Thomas Caulfield

Archive | 2003

SUBSTITUTED ARYL-CYCLOALKANES, AND USE THEREOF AS ANTICANCER AGENTS

Patrick Mailliet; Marc Capet; Gilles Tiraboschi; Thomas Caulfield

Archive | 2002

Substituted carbazoles as tubulin polymerization inhibitors and their use for the treatment of cancer

Thomas Caulfield; Marie-Pierre Cherrier; Cécile Combeau; Patrick Mailliet

Explore More

Collaboration

Dive into the Thomas Caulfield's collaboration.

Top Co-Authors
Avatar

Patrick Mailliet

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gilles Tiraboschi

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Marc Capet

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Abdelazize Laoui

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Anne Minnich

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Daniel G. Mcgarry

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Francois Hamy

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gerard M. Mcgeehan

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gilles Doerflinger

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Jean-François Riou

Centre national de la recherche scientifique

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge